BOCA RATON, Fla., November 12, 2024--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results ...

Shares of TherapeuticsMD Inc. TXMD slid 1.35% to $1.10 Monday, on what proved to be an all-around positive trading session ...

TherapeuticsMD ( NASDAQ:TXMD ) Third Quarter 2024 Results Key Financial Results Net loss: US$567.0k (loss narrowed by... BOCA RATON, Fla., November 12, 2024--TherapeuticsMD, Inc. ("TherapeuticsMD ...

Clearline Capital LP grew its holdings in TherapeuticsMD, Inc. (NASDAQ:TXMD – Free Report) by 18.9% during the second quarter, according to its most recent filing with the Securities and ...

The stock's rise snapped a five-day losing streak.

Major U.S. indexes gained at midday Wednesday as tech stocks climbed after the latest report on consumer inflation reinforced ...

BOCA RATON, Fla., November 12, 2024--TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial ...

Clearline Capital LP grew its holdings in TherapeuticsMD, Inc. (NASDAQ:TXMD – Free Report) by 18.9% during the 2nd quarter, according to the company in its most recent 13F filing with the ...

DeLucia will report to Chief Executive Officer Thane Wettig and will be responsible for leading FibroGen's global finance organization ... at TherapeuticsMD (NASDAQ:TXMD) and was a buy-side ...